Drug Profile
Research programme: cannabinoid receptor 2 agonists - Dompe
Alternative Names: CNR2 agonists - DompeLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Dompe SpA
- Class Analgesics
- Mechanism of Action Cannabinoid receptor CB2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Pain in Italy
- 19 Jul 2016 Early research in Pain in Italy (unspecified route)